Bionic Limb Reconstruction 2021
DOI: 10.1007/978-3-030-60746-3_12
|View full text |Cite
|
Sign up to set email alerts
|

Treatment Strategies for Phantom Limb Pain

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
3
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 93 publications
0
3
0
Order By: Relevance
“…PLP does not yet have a defined pathophysiology and etiology [1]. There are several mechanisms involved in its onset, including central, spinal, or peripheral mechanisms, which explains the multimodal management needed, but also the many difficulties experienced during the treatment [2,3]. The incidence of PLP varies from 42.2 to 78.8% in the literature, and its prevalence is 45-85% [4].…”
Section: Introductionmentioning
confidence: 99%
“…PLP does not yet have a defined pathophysiology and etiology [1]. There are several mechanisms involved in its onset, including central, spinal, or peripheral mechanisms, which explains the multimodal management needed, but also the many difficulties experienced during the treatment [2,3]. The incidence of PLP varies from 42.2 to 78.8% in the literature, and its prevalence is 45-85% [4].…”
Section: Introductionmentioning
confidence: 99%
“…For such cases, the rehabilitation program is foreshortened. Still, we have experienced that regular training of controlled activation of the reinnervated muscles and a prosthesis can further improve the pain situation 32 . Here, shared decision-making is essential as some patients might wear a prosthesis for its potential to reduce pain in the long term 32 , while others might not be interested.…”
Section: Discussionmentioning
confidence: 99%
“…Pemilihan anestesi lokal juga bisa diberikan dengan teknik blokade saraf menggunakan teknik epidural dan perineural. 41 Rekomendasi penatalaksanaan PLP terdiri atas obat-obatan nyeri neuropatik dengan lini pertama yaitu antidepresan (amitriptilin 0,35-0,4mg/kgBB/hari dan antikonvulsan (Gabapentin 30mg/kgBB/hari, Pregabalin 5mg/kgBB/hari), dengan lini kedua yaitu N-methyl-D-aspartate (NMDA) reseptor antagonis (ketamine 0,05-0,6mg/kgBB/hari) dan opioid (Morfin 2,5-5mg/hari).…”
Section: Isiunclassified